Related Experiment Video
Updated: Aug 16, 2026

Functional Assessment of Intestinal Motility and Gut Wall Inflammation in Rodents: Analyses in a Standardized Model of Intestinal Manipulation
Published on: September 11, 2012
Meconium ileus
1Division of Pediatric Surgery, Children's Hospital Medical Center, University of Cincinnati College of Medicine, Ohio.
Abstract:
Meconium ileus is a manifestation of intestinal and pancreatic dysfunction that results in the accumulation of a sticky and inspissated intraluminal meconium, which in most cases results from the autosomal recessive disease cystic fibrosis. Both nonoperative and operative therapies are effective in relieving this small-bowel obstruction; in the past, although less so today, a successful nonoperative treatment was associated with a more favorable outcome. Once the meconium ileus is relieved successfully, and the diagnosis of cystic fibrosis is established, the treatment for the intestinal manifestations of the disease focuses on enzyme replacement to augment patient nutritional status. Simultaneously, the treatment of the life-threatening pulmonary disease focuses on mucous retention and chronic infection in the lungs. Future therapies for patients with cystic fibrosis include lung transplantation, pharmacologic manipulation of the epithelial cell abnormality, and gene transfer therapy into the respiratory epithelium.
Insights
Meconium ileus, often caused by cystic fibrosis, is a bowel obstruction treatable by surgery or non-surgical methods. Post-treatment care focuses on nutrition and lung health for cystic fibrosis patients.
Area of Science:
- Pediatric Gastroenterology
- Pulmonology
- Medical Genetics
Background:
- Meconium ileus is a significant intestinal obstruction in newborns.
- It is frequently associated with cystic fibrosis, an autosomal recessive genetic disorder.
- Both surgical and non-surgical interventions can resolve meconium ileus.
Purpose of the Study:
- To outline the clinical presentation and management of meconium ileus.
- To emphasize the link between meconium ileus and cystic fibrosis.
- To discuss current and future therapeutic strategies for cystic fibrosis.
Main Methods:
- Review of clinical manifestations and treatment outcomes for meconium ileus.
- Discussion of diagnostic criteria for cystic fibrosis.
- Overview of management principles for intestinal and pulmonary manifestations of cystic fibrosis.
Main Results:
- Nonoperative and operative therapies are effective for meconium ileus relief.
- Successful nonoperative treatment was historically linked to better outcomes.
- Management involves enzyme replacement for intestinal issues and respiratory care for lung disease.
Conclusions:
- Meconium ileus necessitates prompt diagnosis and treatment.
- Cystic fibrosis management requires a multidisciplinary approach addressing both gastrointestinal and pulmonary systems.
- Emerging therapies offer hope for improved long-term outcomes in cystic fibrosis patients.
Related Concept Videos
Assessment of the Rectum and Anus
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Upper GI Series: Barium Swallow
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
Lower GI Series: Barium Enema
Procedure Details
The examination begins by inserting a lubricated rectal tube into the patient's rectum to administer a radiopaque barium solution. The barium flow is carefully...
Intestinal Obstruction I: Introduction
Intestinal Obstruction II: Pathophysiology

